Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 1;21(17):4923-7.
doi: 10.1016/j.bmc.2013.06.068. Epub 2013 Jul 11.

Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors

Affiliations

Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors

Lidiya Stavitskaya et al. Bioorg Med Chem. .

Abstract

A series of ring-constrained phenylpropyloxyethylamines, partial opioid structure analogs and derivatives of a previously studied sigma (σ) receptor ligand, was synthesized and evaluated at σ and opioid receptors for receptor selectivity. The results of this study identified several compounds with nanomolar affinity at both σ receptor subtypes. Compounds 6 and 9 had the highest selectivity for both σ receptor subtypes, compared to μ opioid receptors. In addition, compounds 6 and 9 significantly reduced the convulsive effects of cocaine in mice, which would be consistent with antagonism of σ receptors.

Keywords: Antagonists; Opioid; Phenylpropyloxyethylaminesl; Sigma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cocaine-induced convulsions. (A) Pretreatment of Swiss Webster mice with compound 6 (0–30 mg/kg ip), followed by a convulsive dose of cocaine (70 mg/kg ip) produced a reduction in the convulsive effects of cocaine. (B) Pretreatment of Swiss Webster mice with compound 9 (0–10 mg/kg ip), followed by a convulsive dose of cocaine (70 mg/kg ip) produced a dose-dependent reduction in the convulsive effects of cocaine. *p < 0.05; **p < 0.01; Fisher’s exact test.
Scheme 1.
Scheme 1.
Synthesis of 3, 4 6, 7, 9 and 10. Reagents and conditions: A, (a) HCHO, HCOOH, reflux; (b) cinnamyl bromide or 1-bromo-3-phenylpropane, NaH, DMF. 50 °C, 3 h. B, (c) N-methyl-phenethylamine, EtOH, reflux; (d) 1-bromo-3-phenylpropane, NaH, DMF, 50 °C, 3 h; (e) 3-phenylpropylamine, EtOH, reflux; (f) HCHO, HCOOH, reflux; (g) 1-bromo-3-phenylpropane, NaH, DMF, 50 °C.

Similar articles

Cited by

References

    1. Carrera MR; Meijler MM; Janda KD Bioorg. Med. Chem. 2004, 12, 5019. - PubMed
    1. Matsumoto RR Expert Rev. Clin. Pharmacol. 2009, 2. 351. - PMC - PubMed
    1. Matsumoto RR; McCracken KA; Pouw B; Zhang Y; Bowen WD Neuropharmacology 2002, 42, 1043. - PubMed
    1. Maurice T; Martin-Fardon R; Romieu P; Matsumoto RR Neurosci. Biobehav. Rev. 2002, 26, 499. - PubMed
    1. Shibayama M; Ooi K; Johnson R; Scott B; Itoh Y. Curr. Genet. 2002, 42, 59. - PubMed

Publication types

MeSH terms

LinkOut - more resources